ΔNp63 promotes IGF1 signalling through IRS1 in squamous cell carcinoma.
Saved in:
| Title: | ΔNp63 promotes IGF1 signalling through IRS1 in squamous cell carcinoma. |
|---|---|
| Authors: | Frezza V; Department of Experimental Medicine, TOR University of Rome 'Tor Vergata', Rome 00133, Italy., Fierro C; Department of Experimental Medicine, TOR University of Rome 'Tor Vergata', Rome 00133, Italy., Gatti E; Department of Experimental Oncology European Institute of Oncology, Milan 20139, Italy., Peschiaroli A; National Research Council of Italy Institute of Translational Pharmacology (IFT-CNR), Rome 00133, Italy., Lena AM; Department of Experimental Medicine, TOR University of Rome 'Tor Vergata', Rome 00133, Italy., Petruzzelli MA; Istituto Dermopatico dell'Immacolata, IRCCS,, Rome 00163, Italy., Candi E; Department of Experimental Medicine, TOR University of Rome 'Tor Vergata', Rome 00133, Italy.; Istituto Dermopatico dell'Immacolata, IRCCS,, Rome 00163, Italy., Anemona L; Department of Experimental Medicine, TOR University of Rome 'Tor Vergata', Rome 00133, Italy., Mauriello A; Department of Experimental Medicine, TOR University of Rome 'Tor Vergata', Rome 00133, Italy., Pelicci PG; Department of Experimental Oncology European Institute of Oncology, Milan 20139, Italy., Melino G; Department of Experimental Medicine, TOR University of Rome 'Tor Vergata', Rome 00133, Italy.; Medical Research Council, Toxicology Unit, University of Cambridge, Leicester LE1 9HN, UK., Bernassola F; Department of Experimental Medicine, TOR University of Rome 'Tor Vergata', Rome 00133, Italy. |
| Source: | Aging [Aging (Albany NY)] 2018 Dec 28; Vol. 10 (12), pp. 4224-4240. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Impact Journals, LLC Country of Publication: United States NLM ID: 101508617 Publication Model: Print Cited Medium: Internet ISSN: 1945-4589 (Electronic) Linking ISSN: 19454589 NLM ISO Abbreviation: Aging (Albany NY) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
